Relapsing-remitting multiple sclerosis and Withdrawal syndrome

Summary:

Withdrawal syndrome is found among people with Relapsing-remitting multiple sclerosis, especially for people who are female, 40-49 old.

The study analyzes which people have Withdrawal syndrome with Relapsing-remitting multiple sclerosis. It is created by eHealthMe based on reports of 42 people who have Relapsing-remitting multiple sclerosis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Relapsing-remitting multiple sclerosis?

Relapsing-remitting multiple sclerosis (reoccurrence of an inflammatory disease in which the insulating covers of nerve cells in the brain and spinal cord are damaged) is found to be associated with 126 drugs and 178 conditions by eHealthMe. Check the latest studies of Relapsing-remitting multiple sclerosis.

What is Withdrawal syndrome?

Withdrawal syndrome (a discontinuation syndrome is a set of symptoms occurred due to discontinuation of substance) is found to be associated with 1,004 drugs and 1,486 conditions by eHealthMe. Check the latest studies of Withdrawal syndrome.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

42 people who have Relapsing-Remitting Multiple Sclerosis and Withdrawal Syndrome are studied.

Would you have Withdrawal syndrome when you have Relapsing-remitting multiple sclerosis?

Gender of people who have Relapsing-Remitting Multiple Sclerosis and experienced Withdrawal Syndrome *:

female: 97.44 %
male: 2.56 %

Age of people who have Relapsing-Remitting Multiple Sclerosis and experienced Withdrawal Syndrome *:

Common co-existing conditions for these people *:

Joint Pain: 7 people, 16.67%
Headache (pain in head): 7 people, 16.67%
Neuralgia (pain in one or more nerves): 6 people, 14.29%
Stress And Anxiety: 4 people, 9.52%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 4 people, 9.52%
Migraine (headache): 4 people, 9.52%
Arrhythmias (irregular heartbeat): 4 people, 9.52%
Heart Palpitations (feelings or sensations that your heart is pounding or racing): 3 people, 7.14%
Pulmonary Embolism (blockage of the main artery of the lung): 2 people, 4.76%
Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 1 person, 2.38%

Common drugs taken by these people *:

Ocrevus: 10 people, 23.81%
Gilenya: 7 people, 16.67%
Gabapentin: 6 people, 14.29%
Synthroid: 6 people, 14.29%
Gravol: 6 people, 14.29%
Benadryl: 5 people, 11.90%
Cymbalta: 5 people, 11.90%
Fingolimod: 5 people, 11.90%
Celebrex: 4 people, 9.52%
Propranolol Hydrochloride: 4 people, 9.52%

Common symptoms for these people *:

Fatigue (feeling of tiredness): 20 people, 47.62%
Headache (pain in head): 19 people, 45.24%
Nausea (feeling of having an urge to vomit): 17 people, 40.48%
Multiple Sclerosis Relapse (reoccurrence of a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 17 people, 40.48%
Rashes (redness): 16 people, 38.10%
Malaise (a feeling of general discomfort or uneasiness): 15 people, 35.71%
Drug Ineffective: 14 people, 33.33%
Weight Increased: 14 people, 33.33%
Joint Pain: 14 people, 33.33%
The Flu (the flu is caused by an influenza virus): 14 people, 33.33%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Withdrawal syndrome?

- Check whether Withdrawal syndrome is associated with a drug or a condition

Related studies:

How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Withdrawal syndrome and Relapsing-remitting multiple sclerosis, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.